Investors
Reporting
Non-financial reporting

Our social impact

How we contribute to a better tomorrow for all
Patient
Number of patients treated with Roche medicines
•Number of patients treated with patented medicines
•Number of patients treated with off- patent medicines
Number of tests conducted with Diagnostics products (in billions)
Number of Roche medicines on the WHO list of essential medicines
Number of patients included in clinical trials
- % of patients participating from low and low-middle income countries
Number of new molecular entities (NMEs) in clinical development
Number of major regulatory filings completed (Pharmaceuticals)
Number of FDA Breakthrough Therapy designations
Number of new medicines launched
Number of Diagnostics key product launches
Grants, Sponsorships and Donations to Healthcare and Patient Organisations (mCHF)
2022
14,234,450
2,571,423
11,663,027
29
32
267,377
1.43%
87
10
1
2
15
292✔ PwC CH
2021
16,357,184
1,402,100
14,955,084
27
32
244’517
1.46%
80
16
2
3
16
270
2020
28,868,306
2,286,113
26,582,193
23.4
32
235,186
1.14%
89
11
4
4
13
303
Employees
Number of employees (full-time equivalents - FTE)
• Pharmaceuticals
•Chugai
•Diagnostics
•Corporate and others
% FTEs by Age Group:
• <30 years old
• 30-50 years old
• >50 years old
Percentage of total employees covered by collective bargaining agreements
Percentage of employees on part time
Percentage of women in total workforce
Percentage of women in management
Percentage of women on the Corporate Executive Committee
Percentage of women on the Board
Percentage of women in executive positions (1)
Percentage of Underrepresented Nationalities in Executive Positions
Total number of new employee hires
Internal recruitment rate
Employee total turnover rate (fluctuation)
Percentage of voluntary turnover
Average training hours per employee based on our Learning Management Systems (2)
Training hours:
- Pharmaceuticals
- Diagnostics
- Chugai
- Group functions & others
Training costs per headcount (CHF)
Employee engagement (eSAT)
Roche Accident Rate (on a yearly basis)
Number of work related fatalities
Lost time incident frequency rate
Total number of lost time incidents
Roche Group Help & Advice Line Requests
Roche Group SpeakUp Line cases
Alleged Business Ethics Incidents
Number of employees terminated due to unethical behavior
Number of grievances about human rights impacts filed, addressed and resolved through formal grievance mechanism
103,613 ✔ PwC CH
46,793 ✔ PwC CH
7,822 ✔ PwC CH
39,961 ✔ PwC CH
9,037 ✔ PwC CH

11.6% ✔ PwC CH
63.7% ✔ PwC CH
24.7% ✔ PwC CH
19.2% ✔ PwC CH
11.5%
51.1% ✔ PwC CH
43.6% ✔ PwC CH
40.0% ✔ PwC CH
30.0% ✔ PwC CH
36.7% ✔ PwC CH
15.6%
12,672 ✔ PwC CH
69.5% ✔ PwC CH
8.4% ✔ PwC CH
5.8% ✔ PwC CH
31.7 ✔ PwC CH
3,430,401
1,625,579
1,450,176
100,901
253,745
1,172 ✔ PwC CH
N/A
0.047 ✔ PwC CH
0 ✔ PwC CH
0.251 ✔ PwC CH
238 ✔ PwC CH
11
135
723
112
11
100,920
46,889
7,711
39,266
7,054

11%
63%
25%
20.3%
11.2%
50.9%
43.8%
40.0%
25.0%
35.9%
10,346
72.4%
11.3%
6.6%
28.8
1,075
80
0.040
0
0.285
270
20
161
568
88
4
101,465
49,762
7,611
37,907
6,185

N/A
N/A
N/A
20.1%
11.1%
51.0%
44.0%
40.0%
25.0%
31.9%
11,394
67.4%
7.7%
4.4%
26.0
1,077
N/A
0.042
0
0.297
277
21
181
646
178
11
Suppliers
% of supplier agreements including the Roche Supplier Code of Conduct (or equivalent)
% of suppliers risk assessed
Number of supplier safety, health and environment (SHE) audits conducted with contract manufacturers
Number of supplier sustainability audits
Number of business partners terminated due to unethical behavior
Number of sustainability audits triggered by high human rights risk
100%
100%
40
51
6
3
100%
100%
39
26
8
N/A
90%
100%
60
38
5
N/A
Communities
Community support by area:
•Humanitarian and social projects (%)
•Science and education (%)
•Arts and culture (%)
•Community involvement (%)
93% ✔ PwC CH
2% ✔ PwC CH
3% ✔ PwC CH
2% ✔ PwC CH
93%
3%
3%
1%
90%
1%
6%
3%

    Our environmental impact

    How we minimize our impact on nature
    KPI
    Eco-balance (million impact points/employee)
    Total energy consumption (TJ/year) - Scope 1, 2, 3 (Business travel only)
    Greenhouse gas emissions (tonnes CO2 equivalents) - Scope 1, 2, 3 (Business travel only)
    Water consumption (million cubic meters per year)
    Organic matter discharged to water ways after treatment (t/year)
    Heavy metals discharged to water ways after treatment (kg/year)
    Hazardous waste (landfilled and incinerated waste in tonnes) (3)
    Non-Hazardous waste (landfilled and incinerated waste in tonnes)
    Energy intensity (GJ/employee) - Scope 1, 2, 3 (Business travel only)
    Share (%) of sustainable electricity
    CO2 intensity (t/employee) - Scope 1, 2, 3 (Business travel only)
    Total number of SHE fines (significant)
    2022
    5.05 ✔ PwC CH
    9,403 ✔ PwC CH
    435,988 ✔ PwC CH
    2.9 ✔ PwC CH
    80 ✔ PwC CH
    137 ✔ PwC CH
    14,587 ✔ PwC CH
    9,087 ✔ PwC CH
    88 ✔ PwC CH
    81.0% ✔ PwC CH
    4.07 ✔ PwC CH
    0 ✔ PwC CH
    2021
    5.22
    8,523
    438,187
    2.7
    76
    131
    15,110
    10,357
    81
    71.8%
    4.16
    2
    2020
    5.6
    9,222
    502,755
    2.8
    76
    174
    13,332
    11,139
    89
    67.8%
    4.85
    0

    Our economic impact

    How we invest in medical advances, create jobs and ensure livelihoods
    KPI
    Income taxes (mCHF)
    Income taxes as % of sales
    Sales (mCHF)
    Research and development core investments (mCHF)
    Research and development as % of sales
    M&D costs (mCHF)
    M&D as % of sales
    Core operating profit (mCHF)
    Core operating profit margin (%)
    Net financial income (expense) (mCHF)
    IFRS Net Income (mCHF)
    Core Earnings Per Share (CHF)
    Operating free cash flow
    Operating free cash flow as % of sales
    Net debt (mCHF)
    Dividend per share (CHF) (4)
    Dividend (bnCHF) (4)
    Payout ratio (dividend per share divided by core EPS)
    Market capitalisation (CHF billions)
    2022
    3429
    5.42%
    63,281
    14,053
    22.21%
    9,546
    15.08%
    22,173
    35.04%
    -1,214
    13,531
    20.3
    17,673
    27.93%
    -15,584
    9.5
    7.688
    47%
    239
    2021
    3,075
    4.90%
    62,801
    13,708
    21.83%
    9,444
    15.04%
    21,897
    34.87%
    -751
    14,935
    20
    19,411
    30.91%
    -18,167
    9.3
    7.526
    47%
    307
    2020
    3,594
    6.16%
    58,323
    12,153
    20.84%
    9,361
    16.05%
    21,536
    36.93%
    -564
    15,068
    19.16
    14,815
    25.4%
    -1,882
    9.1
    7.849
    48%
    267

    The marked figures (✔ PwC CH) were reviewed by PricewaterhouseCoopers AG.

    (1) Percentage of women in executive positions (Global Executives and Corporate Executive Committee) was revised in 2021 and shows an improved methodology.

    (2) The methodology used to calculate average training hours per employee based on Learning Management System (LMS) has been revised in 2022 , therefore 2020 and 2021 data have been restated with the new methodology.

    (3) The increase in 2021 in hazardous waste is due to the reallocation of electronic waste to hazardous waste

    (4) For the year 2022 as proposed by the Board of Directors

    We create value for all our stakeholders and track our performance against key financial and non-financial indicators.

    These indicators are defined in our "Basis for Preparation of Non-financial Information 2022" and grouped under our main areas of engagement:

    Discover more